Market Cap (In INR)
628.52 Billion
Revenue (In INR)
58.48 Billion
Net Income (In INR)
12.01 Billion
Avg. Volume
593.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 21983.4-30499.9
- PE
- 47.0
- EPS
- 629.34
- Beta Value
- 0.013
- ISIN
- INE358A01014
- CUSIP
- -
- CIK
- -
- Shares
- 21249300.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Mr. Sridhar Kadangode
- Employee Count
- -
- Website
- https://www.abbott.co.in
- Ipo Date
- 2000-01-03
- Details
- Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, and vaccines, as well as multispecialty products for insomnia, vitamin D, pre-term labor, and pain management; and anti-infectives, cardio-diabetic, hormones, respiratory, hepatic, consumer care, gastro. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
More Stocks
-
002808
-
GSMLG&S Minerals, Inc.
GSML
-
018470Choil Aluminum Co., Ltd.
018470
-
SBXSynBiotic SE
SBX
-
SRS
-
4553
-
IB
-
BTGGFBitcoin Group SE
BTGGF